Glitinides nonsulfonylurea secretagogues

Glitinides, like sulfonylureas, act at the K+-ATP channels to augment glucose-stimulated insulin secretion. Glitinides differ from sulfonylureas by having a more rapid onset and shorter duration of action, primarily lowering postprandial glucose levels. They are only effective in individuals with viable pancreatic b-cells and are therefore not suitable for individuals with T1DM. Repaglinide and nateglinide (Figure 7) are the two glitinides approved by the FDA for use in the USA.

Diabetes 2

Diabetes 2

Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...

Get My Free Ebook


Post a comment